Tsuruha Holdings Inc.

3391.T
Pharmaceutical Retailers
2026/01/16 Updated
Market Cap: $7.5B (¥1.2T)
Stock Price: $16.41 (¥2,600)
Exchange Rate: 1 USD = ¥158.48

Notice Regarding Changes to the Shareholder Benefits Program

Following the business integration with Welcia Holdings on December 1, 2025, the content of the shareholder benefits will be changed starting from the 2026 February fiscal year, providing gift certificates worth 5,000 yen to shareholders holding 100 shares or more.

Importance:
Page Updated: January 8, 2026
IR Disclosure Date: January 8, 2026

Key Figures

  • Shareholder gift certificate 5,000 yen: For shareholders holding 100 to less than 500 shares
  • Shareholder gift certificate 10,000 yen: For shareholders holding 500 to less than 1,000 shares
  • Shareholder gift certificate 15,000 yen: For shareholders holding 1,000 shares or more

AI要約

Overview of Changes to the Shareholder Benefits Program

Tsuruha Holdings Inc. will merge management with Welcia Holdings on December 1, 2025, becoming a drugstore and dispensing pharmacy chain operating in all 47 prefectures nationwide. Taking this opportunity, the shareholder benefits program will be revised to enhance shareholder investment appeal. Previously, only shareholders holding 500 shares or more were eligible, but after the change, those holding 100 shares or more will also qualify, and the value of the shareholder gift certificates will be increased.

Details and Implementation Timing of the Changes

The revised shareholder benefits gift certificates are 5,000 yen for 100 to less than 500 shares, 10,000 yen for 500 to less than 1,000 shares, and 15,000 yen for 1,000 shares or more; shareholders can also choose donations equivalent to these amounts. The long-term holding benefit remains at a 1,000 yen gift certificate granted to shareholders holding 500 shares or more for 3 years or longer. These changes will apply from the 2026 February fiscal year benefits (based on the shareholder registry as of the end of February 2026).

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.